Related Experiment Videos
Cytotoxic activation of complement by mouse pancreatic islet cells
Diabetes
|August 1, 1980
Summary
Human serum damages mouse pancreatic islet cells by activating complement. This immune response, triggered via the alternative pathway, impairs cell function and insulin release, highlighting cellular discriminators.
Area of Science:
- Immunology
- Cell Biology
- Endocrinology
Background:
- Human serum can affect pancreatic islet cell function.
- The precise mechanisms of serum-mediated islet cell damage are not fully understood.
Purpose of the Study:
- To investigate the effects of human serum on mouse pancreatic islet cells.
- To elucidate the underlying mechanisms of serum-induced islet cell dysfunction and damage.
Main Methods:
- Utilized Rubidium-86 (Rb+) uptake assays to measure islet cell function.
- Performed electron microscopy to assess cellular damage.
- Investigated complement activation pathways.
Main Results:
- Human serum irreversibly inhibited Rb+ accumulation in mouse islet cells.
- Serum treatment caused significant islet cell damage, including plasma membrane rupture and mitochondrial swelling.
- Serum induced prompt insulin release, unaffected by epinephrine.
- Complement activation via the alternative pathway was implicated.
Conclusions:
- Mouse islet cells can activate the alternative complement pathway in response to human serum.
- Cellular discriminators related to species, organ, and self appear to control complement triggering.
- These findings shed light on immune-mediated islet cell injury.